# Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure

> **NCT00575419** · PHASE1 · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 6 (actual)

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT00575419
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2014-09-15
- **Final completion:** 2014-09-15
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2019-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575419, "Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00575419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*